Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 1, 2026

Primary Completion Date

January 1, 2029

Study Completion Date

January 1, 2029

Conditions
Multiple Sclerosis
Interventions
PROCEDURE

Autologous haemopoietic stem cell transplantation

"Immuno-ablation and autologous CD34 selected hematopoietic stem cell transplantation (HSCT).~Stem cell mobilization with cyclophosphamide 2g/m2 and filgrastim 10 ug/kg/d x 5 day.~Stem cell collection with cobe cpectra stem cell purification with Miltenyi CliniMACS Stem cell transplant conditioning with busulphan 3.2 mg/kg ; fludarabine 30mg/m2 or cladribine 10mg ;cytarabine 1-2g/m2 or idarubicin 8mg/m2;cyclophosphamide 40mg/kg followed by CD34 selected autologous hematopoietic stem cell transplant."

All Listed Sponsors
lead

Tianjin Medical University General Hospital

OTHER